Indications -- Psoriasis/Chronic Inflammation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Indications -- Psoriasis/Chronic Inflammation

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Icebrg who wrote (407)	5/16/2003 12:54:18 AM
From: Miljenko Zuanic	Read Replies (1) of 631

<<[This is the MLN02 Crohn's abstract. It appears that they might have used too low a dose].>> Too low dose for Chron's and inverse dose response for UC (29% of patients receiving 0.5 mg/kg and 14% receiving 2.0 mg/kg had an MBS of 0 (normal mucosa) compared with 8% of those who received placebo (p=0.01).) does not go together at all. Something strange is going on??? Miljenko

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next